Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

The pain and the gain of treating patients with acute coronary syndromes-can the two be separated?

Brener SJ, Bhatt DL.

Am Heart J. 2009 Mar;157(3):399-401. doi: 10.1016/j.ahj.2008.11.012. Epub 2009 Jan 16. No abstract available.

PMID:
19249407
[PubMed - indexed for MEDLINE]
2.

Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk.

Joyner CD, Peters RJ, Afzal R, Chrolavicius S, Mehta SR, Fox KA, Granger CB, Franzosi MG, Flather M, Budaj A, Bassand JP, Yusuf S.

Am Heart J. 2009 Mar;157(3):502-8. doi: 10.1016/j.ahj.2008.10.028.

PMID:
19249421
[PubMed - indexed for MEDLINE]
3.

Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.

Karthikeyan G, Mehta SR, Eikelboom JW.

Expert Rev Cardiovasc Ther. 2009 Mar;7(3):241-9. doi: 10.1586/14779072.7.3.241.

PMID:
19296760
[PubMed - indexed for MEDLINE]
4.

Fondaparinux versus enoxaparin in acute coronary syndromes.

Majure DT, Aberegg SK.

N Engl J Med. 2006 Jun 29;354(26):2829; author reply 2830. No abstract available.

PMID:
16807423
[PubMed - indexed for MEDLINE]
Free Article
5.

Factor Xa inactivation in acute coronary syndrome.

Barantke M, Bonnemeier H.

Curr Pharm Des. 2008;14(12):1186-90. Review.

PMID:
18473865
[PubMed - indexed for MEDLINE]
6.

Advances in antithrombotic therapy in acute myocardial infarction: the ExTRACT-TIMI 25 and OASIS-6 Trials.

Alexander JH, Harrington RA.

Curr Cardiol Rep. 2006 Jul;8(4):279-81. No abstract available.

PMID:
16883666
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial.

Jolly SS, Faxon DP, Fox KA, Afzal R, Boden WE, Widimsky P, Steg PG, Valentin V, Budaj A, Granger CB, Joyner CD, Chrolavicius S, Yusuf S, Mehta SR.

J Am Coll Cardiol. 2009 Jul 28;54(5):468-76. doi: 10.1016/j.jacc.2009.03.062.

PMID:
19628124
[PubMed - indexed for MEDLINE]
Free Article
8.

Acute coronary syndromes: oral factor Xa inhibitors in acute coronary syndromes.

Tapp L, Wrigley B, Lip GY.

Nat Rev Cardiol. 2009 Oct;6(10):619-20. doi: 10.1038/nrcardio.2009.160. No abstract available.

PMID:
19773793
[PubMed - indexed for MEDLINE]
9.

Fondaparinux: an overview.

Nadar SK, Goyal D, Shantsila E, Banerjee P, Lip GY.

Expert Rev Cardiovasc Ther. 2009 Jun;7(6):577-85. doi: 10.1586/erc.09.19.

PMID:
19505272
[PubMed - indexed for MEDLINE]
10.

Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.

Sculpher MJ, Lozano-Ortega G, Sambrook J, Palmer S, Ormanidhi O, Bakhai A, Flather M, Steg PG, Mehta SR, Weintraub W.

Am Heart J. 2009 May;157(5):845-52. doi: 10.1016/j.ahj.2009.02.017.

PMID:
19376310
[PubMed - indexed for MEDLINE]
11.

Enoxaparin in elective percutaneous coronary intervention.

Hamon M, Riddell JW.

N Engl J Med. 2006 Dec 28;355(26):2788-9; author reply 2790-1. No abstract available.

PMID:
17195309
[PubMed - indexed for MEDLINE]
12.

Enoxaparin in elective percutaneous coronary intervention.

Schuler J, Altenberger J, Heigert M.

N Engl J Med. 2006 Dec 28;355(26):2789-90; author reply 2790-1. No abstract available.

PMID:
17193723
[PubMed - indexed for MEDLINE]
13.

Enoxaparin in elective percutaneous coronary intervention.

Bhala N.

N Engl J Med. 2006 Dec 28;355(26):2788; author reply 2790-1. No abstract available.

PMID:
17192548
[PubMed - indexed for MEDLINE]
Free Article
14.

Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.

Spinler SA, Ou FS, Roe MT, Gibler WB, Ohman EM, Pollack CV, Alexander KP, Peterson ED.

Pharmacotherapy. 2009 Jun;29(6):631-8. doi: 10.1592/phco.29.6.631.

PMID:
19476416
[PubMed - indexed for MEDLINE]
15.

Guidelines for anticoagulant use in acute coronary syndromes.

Bassand JP, Hamm C.

Lancet. 2008 Aug 16;372(9638):532-3; author reply 533-4. doi: 10.1016/S0140-6736(08)61227-1. No abstract available.

PMID:
18707977
[PubMed - indexed for MEDLINE]
16.

Clinical investigation in ACS and PCI: shooting in the dark at a moving target.

Dangas G.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):365-6. doi: 10.1002/ccd.22180. No abstract available.

PMID:
19642185
[PubMed - indexed for MEDLINE]
17.

Spotlight on fondaparinux sodium in acute coronary syndromes.

Blick SK, Orman JS, Wagstaff AJ, Scott LJ.

BioDrugs. 2008;22(6):413-5. doi: 10.2165/0063030-200822060-00007. Review.

PMID:
18998758
[PubMed - indexed for MEDLINE]
18.

Low-molecular weight heparin enoxaparin in the treatment of acute coronary syndromes without ST segment elevation.

Mitrovska S, Jovanova S.

Bratisl Lek Listy. 2009;110(1):45-8.

PMID:
19408831
[PubMed - indexed for MEDLINE]
19.

Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

Lopes RD, Alexander KP, Manoukian SV, Bertrand ME, Feit F, White HD, Pollack CV Jr, Hoekstra J, Gersh BJ, Stone GW, Ohman EM.

J Am Coll Cardiol. 2009 Mar 24;53(12):1021-30. doi: 10.1016/j.jacc.2008.12.021. Erratum in: J Am Coll Cardiol. 2009 Apr 21;53(16):1473.

PMID:
19298914
[PubMed - indexed for MEDLINE]
Free Article
20.

Blood thinner cuts risk of bleeding in half.

[No authors listed]

Health News. 2006 Jan;12(1):9. No abstract available.

PMID:
16447318
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk